Stifel (SF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SF posts Y/Y growth in total and fee-based assets for May 2025, supported by market gains and client asset strength.
SF grows client assets by 7% and fee-based assets by 11% y/y in April, which have been steady despite equity market volatility.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has delivered a solid set of full-year numbers, and analysts at Stifel reckon it's navigating the tough US academic funding environment as well as could be hoped. The medical imaging specialist posted $3.1 million in revenue for 2024, more than triple the year before and just above guidance.
Stifel Financial faced multiple legal setbacks in Q1 2025, leading to a 20% stock drop and missed earnings expectations due to legal charges. In Q1 2025, the company recorded record net revenues of $1.255 billion and an all-time high in quarterly revenue from its asset management division. Stifel Financial is making notable advances in technology and preparing for future market demands for wealth management talent.
Stifel Financial Corp. (NYSE:SF ) Q1 2025 Earnings Conference Call April 23, 2025 9:30 AM ET Company Participants Joel Jeffrey - Head, Investor Relations Ron Kruszewski - Chairman & Chief Executive Officer Jim Marischen - Chief Financial Officer Conference Call Participants Devin Ryan - Citizens Mike Brown - Wells Fargo Securities Alex Blostein - Goldman Sachs Steven Chubak - Wolfe Research Bill Katz - TD Cowen Chris Allen - Citi Operator Good day, and welcome to the Stifel Financial First Quarter 2025 Financial Results Conference Call. Today's conference is being recorded.
Stifel Financial (SF) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $1.61 per share. This compares to earnings of $1.49 per share a year ago.
Stifel (SF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stifel Nicolaus Europe has begun covering ACG Metals Ltd (LSE:ACG, OTC:ACGAF) with a ‘buy' rating, offering investors an independent analysis of the company's strategy and operations. The research is led by Andrew Breichmanas, a senior analyst in metals and mining, and is expected to raise ACG's profile among institutional and retail investors.
Paul Matteis, Stifel head of biotech research, joins 'The Exchange' to discuss the biotech trade under a new FDA amid the top vaccine official resigning.
Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, how to position, and more.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Stifel Financial (SF) have what it takes?